Welcome to LookChem.com Sign In|Join Free
The company logo of Doublewin Biological Technology Co., Ltd.(expird)

Doublewin Biological Technology Co., Ltd.(expird)

Free supplier Enterprise Certification

Free
supplier
4th
years

Doublewin Biological Technology Co., Ltd.(expird)

Business Type:Lab/Research institutions

Audited Supplier

Main Products:
Year Established:
2021
Home>>Products>>Fat Burning Pharmaceutical Raw Materials Rimonabant / Acomplia

Products Categories

Product Certification&
Enterprise Certification

More Detail

Doublewin Biological Technology Co., Ltd.(expird)

Country: China (Mainland)

Business Type:Lab/Research institutions

Fat Burning Pharmaceutical Raw Materials Rimonabant / Acomplia

CAS NO.168273-06-1

  • FOB Price: USD: 20.00-45.00 /Metric Ton Get Latest Price
  • Min.Order: 10 Gram
  • Payment Terms: T/T,
  • Available Specifications:

    A(1-10)Metric TonA(20-50)Metric Ton

Contact Supplier

Product Details

Keywords

  • Rimonabant
  • pharmaceutical anabolic steroids
  • 168273-06-1

Quick Details

  • ProName: Fat Burning Pharmaceutical Raw Materia...
  • CasNo: 168273-06-1
  • Molecular Formula: C22H21Cl3N4O
  • Appearance: white to almost white powder
  • Application: It can be used as pharmaceutical mater...
  • DeliveryTime: Shipped within 24 hours of receiving t...
  • PackAge: Aluminum foil bag/hidden
  • Port: ShenZhen
  • ProductionCapacity: 1000 Kilogram/Day
  • Purity: 99%
  • Storage: Shading, confined preservation
  • Transportation: FedEx,DHL,EMS, special line delivery
  • LimitNum: 10 Gram

Superiority

 1. Quality

Our company is a professional leading supplier in China in

the pharmaceutical area and every batch of steroid powders have to be

tested by our QC (quality control) before steroids are allowed to sell.

2. Delivery

Mass stock for steroids, so we could be able to pack your powders

within 24 hours after your payment confirmed, and the corresponding

picture of your powders' parcel will be sent to you. The lead time within 15 days.

3. Package

A safe and professional disguised package can be guaranteed.

4. Payment

Bitcoin, MoneyGram, , bank transfers

5. Price

The best prices you're sure to be satisfied with, the more you buy, the more competitive prices you will get.

Details

Pharmaceutical Raw Materials Rimonabant / Acomplia CAS 168273-06-1 For Fat Burning

 

 

Abstract

 

Rimonabant is a weight loss drug, can significantly reduce weight, reduce waist circumference and reduce risk factors for cardiovascular disease, but also can improve blood lipids and insulin resistance and metabolic syndrome, especially for the presence of clinical obesity or heart disease people at risk.

Rimonabant as a new weight loss drug, can also be used to quit smoking. Not only lose weight, but also lower blood pressure, cholesterol and blood sugar, clinical study found that subjects taking one to two months later, the weight can be reduced on average six to eight kilograms.

 

An experimental wonder drug, Rimonabant, helps you lose weight, quit smoking and it also helps protect your heart. Trials have shown that 33% of people on Rimonabant lost 10% of body weight and kept their weight down for two years - this is a record, no other diet drug has managed to keep a person's weight down for so long. The second 33% lost 5% of body weight and kept it down. As well as keeping you lean, the drug also helps you quit the smoking habit. This will be of great interest for many smokers who are afraid to give up because they say they will put on loads of weight if they do.

 

 

COA

 


Product Name
Rimonabant Batch No. 170728

Report Date
2017/07/28
Test Items Specification Test Results
Appearance Off white crystalline powder Off white crystalline powder
Melting Point 233.2oC~236.1oC 230oC~240oC
L.O.D 0.23% ≤0.5%
Solubility Conforms Freely soluble in methanol
Heavy metals(Pb) 10ppm ≤10ppm
Assay 99.65% ≥99.5%
T.L.C. Only one spot Only one spot

 

 

Function 

Rimonabant / Acomplia is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved in 38 countries including the E.U., Mexico, and Brazil.

Rimonabant / Acomplia,Developed by Sanofi-Aventis, Acomplia (Rimonabant) is a selective CB1 receptor antagonist. In other words, Rimonabant is intended to promote weight loss by reducing the total number of calories an individual consumes on a daily basis.

Rimonabant / Acomplia works by blocking endogenous from binding to neuronal CB1 receptors. The activation of these receptors by endogenous , such as anadamide, increases an individuals appetite. By blocking the activation of the receptors, appetite suppression may occur.

 

 

How does rimonabant work

 

Acomplia acts by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle2.

Acomplia switches off the same brain circuits that make people hungry when they smoke cannabis.
CB1 receptor blockade with Acomplia acts to decrease the overactivity of the endocannabinoid system (EC system).3,4 The EC system is a recently characterised physiological system that includes receptors such as the CB1 receptor and it has been shown to play an important role in regulating body weight and in controlling energy balance, as well as glucose and lipid (or fat) metabolism.

 

Dosage

 

It is expected that the usual dose of rimonabant will be 20 mg once daily before breakfast. No dosage adjustment is recommended for the elderly, but this agent should be used with caution in patients older than 75 years of age.

 

Although rimonabant can be used in patients with mild hepatic impairment, caution is advised in patients with moderate impairment. This medication is not recommended for those with severe hepatic impairment.

 

Rimonabant may be used cautiously in patients with mild-to-moderate renal impairment, but it is not recommended for patients who are severely renally impaired.

 

 

Email:doublewin-eunice@nandrolonesteroid.com
WhatsApp:+86 17683962426
Skype:eunice1998

Hot Product